Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/3061827

Download in:

View as

General Info

PMID
3061827